Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 • 3,152 citations
Cortisone in Ulcerative Colitis
1955 • 2,701 citations
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 • 2,656 citations
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
1994 • 1,694 citations
Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
1999 • 1,107 citations
Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
1999 • 755 citations
Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.
1991 • 491 citations
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
2001 • 427 citations
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
2001 • 392 citations
Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
1992 • 325 citations
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
1993 • 324 citations
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
2001 • 296 citations
Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease
1996 • 280 citations
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
1999 • 255 citations
ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease
2001 • 224 citations
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis
1992 • 220 citations
A critical review of cyclosporine therapy in inflammatory bowel disease
1995 • 191 citations
Infliximab for refractory ulcerative colitis
2001 • 138 citations
Humanized antibodies for therapy
1991 • 110 citations
Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.
1997 • 97 citations
Serum Tumor Necrosis Factor Activity in Inflammatory Bowel Disease
1992 • 80 citations
A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
2000 • 78 citations
Clinical and Laboratory Indicators of Extent of Ulcerative Colitis
1988 • 60 citations
Efficacy of Intravenous Cyclosporine for Steroid Refractory Attacks of Ulcerative Colitis
1995 • 56 citations
Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.
1997 • 41 citations
The Plain Abdominal Film Accurately Estimates Extent of Active Ulcerative Colitis
1991 • 28 citations
Soluble lnterleukin-2 Receptor, lnterleukin-6 and Interleukin-1 β in Patients with Crohn’s Disease and Ulcerative Colitis: Preoperative Levels and Postoperative Changes of Serum Concentrations
1992 • 27 citations
Infliximab therapy for severe ulcerative colitis refractory to steroid therapy: Report of two cases
2000 • 1 citations